A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2019; you can also visit the original URL.
The file type is application/pdf
.
Pioglitazone and bladder cancer: a propensity score matched cohort study
2012
British Journal of Clinical Pharmacology
CONCLUSION The results suggest that pioglitazone may not be significantly associated with an increased risk of bladder cancer in patients with type 2 diabetes. Pioglitazone and bladder cancer Br J Clin Pharmacol / 75:1 / 257
doi:10.1111/j.1365-2125.2012.04325.x
pmid:22574756
pmcid:PMC3555065
fatcat:imqhqmakq5aqdow6xknnfuaoti